The Takeda-backed cardiovascular therapeutics developer has agreed up to $300m in fresh funding from Bain Capital Life Sciences and Bain Capital Private Equity.

The Dexcel Pharma-backed immunotherapy discovery technology developer’s latest round was led by Koch Disruptive Technologies and took its overall funding to $295m.

The Optum-backed medical consumer engagement platform increased its total funding to $256m in a round valuing it at $1.6bn.

Salesforce Ventures, Slack Fund, HubSpot Ventures and Okta Ventures all returned to back the commercial partnership platform developer.

SoftBank Latin American Fund was the largest investor in a round bringing the workflow software provider’s funding to approximately $139m to date.

Atco, Bernick’s and Toyota Ventures were among the LPs in the venture firm’s Fund III, which will concentrate on enterprise software, food and health technology developers.

Voltage regulator producer Empower closed a $45m round featuring Samsung Catalyst Fund while Swisscom and Six-backed spend management software provider Yokoy raised $26m.

The gastrointestinal disorder drug developer was co-founded by researchers from Stanford University.

The PPD-backed clinical trial software provider increased its overall funding to $521m in a series D round valuing it at $2.1bn.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.